%20kooperieren%20im%20Berlin%20Center%20for%20Gene%20und%20Cell%20Therapies%20(BC%20GCT)-3.jpeg)
ProBioGen to Lead GMP Manufacturing Operations at Berlin Center for Gene and Cell Therapies (BC GCT)
First Groundbreaking of BC GCT (from left): Dr. Marion Hitchcock, Managing Director of the Gene & Cell Therapies Incubator Berlin and R&D Strategy & Portfolio Manager at Bayer;..
%20kooperieren%20im%20Berlin%20Center%20for%20Gene%20und%20Cell%20Therapies%20(BC%20GCT)-1.jpeg)
ProBioGen und das Berlin Institute of Health in der Charité (BIH) kooperieren im Berlin Center for Gene und Cell Therapies (BC GCT)
Erster Spatenstich des BC GCT (v.l.): Dr. Marion Hitchcock, Managing Director of the Gene & Cell Therapies Incubator Berlin und R&D Strategy & Portfolio Manager bei Bayer; Dr...
ProBioGen Enters Agreement with Polpharma Biologics to Provide High-Performance Cell Line Development Services
Gdańsk, Poland and Berlin, Germany ̶ May 7, 2025 ProBioGen announced today an agreement with Polpharma Biologics, an international biotech company dedicated to the development and..
GlymaxX®-Enhanced Antibody Now Commercially Available for Innovative Cancer Therapy
Berlin, Germany - April 17, 2025 ProBioGen recognizes the significance of the commercial availability of Ziihera® (zanidatamab-hrii), a therapeutic antibody developed using..
ModeX Therapeutics Leverages ProBioGen's Expertise for Accelerated COVID-19 Antibody Development
Berlin, Germany - May 29, 2024 ProBioGen, a leading contract development and manufacturing organization (CDMO), known for its innovative solutions in cell engineering and..
ProBioGen Partners with MAPP BIOPHARMACEUTICAL, INC. for Groundbreaking Development of Afucosylated Antibody Against Marburg Virus Disease Using GlymaxX Technology
Berlin, Germany - March 13th, 2024 ProBioGen, a leading CDMO of innovative solutions and services for biopharmaceutical development, is pleased to announce the execution of..
ProBioGen to Lead GMP Manufacturing Operations at Berlin Center for Gene and Cell Therapies (BC GCT)
Sep 16, 2025
ProBioGen und das Berlin Institute of Health in der Charité (BIH) kooperieren im Berlin Center for Gene und Cell Therapies (BC GCT)
Sep 16, 2025
ProBioGen Enters Agreement with Polpharma Biologics to Provide High-Performance Cell Line Development Services
May 7, 2025
ProBioGen Successfully Completes CMC Development Milestones for Marea’s Promising Acromegaly Therapeutic
Mar 6, 2025
ProBioGen Launches New Website to Enhance User Experience and Streamline Access to Expanded Portfolio
Feb 4, 2025
Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development
Nov 5, 2024
ModeX Therapeutics Leverages ProBioGen's Expertise for Accelerated COVID-19 Antibody Development
May 29, 2024
ProBioGen and DIOSynVax Partner to Manufacture Groundbreaking Multivalent Vaccine for Hemorrhagic Fever
Mar 27, 2024
ProBioGen Partners with MAPP BIOPHARMACEUTICAL, INC. for Groundbreaking Development of Afucosylated Antibody Against Marburg Virus Disease Using GlymaxX Technology
Mar 13, 2024
